𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study

✍ Scribed by P. Rinaldi; L. Spazzafumo; R. Mastriforti; P. Mattioli; M. Marvardi; M. C. Polidori; A. Cherubini; G. Abate; L. Bartorelli; S. Bonaiuto; A. Capurso; D. Cucinotta; M. Gallucci; M. Giordano; M. Martorelli; G. Masaraki; A. Nieddu; C. Pettenati; P. Putzu; V. A. Tammaro; P. F. Tomassini; C. Vergani; U. Senin; P. Mecocci


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
78 KB
Volume
20
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Considerable suffering is experienced by carers of patients with dementia. Most existing studies do not consider the coexistence of subjective and objective aspects that cause, interacting to each other, this suffering.

Objectives

In this study we: (1) define the high‐risk group of caregivers on the bases of the scores obtained on the four scales evaluating burden, distress, depression and anxiety (BDDA) taken into account simultaneously and (2) evaluate risk factors related to the high level of BDDA.

Subjects and methods

419 elderly outpatients with dementia and their caregivers were enrolled. Patients were evaluated for their cognitive, neuropsychological and functional impairment and for comorbidity. Caregivers were evaluated with four scales for the assessment of burden, distress related to neuropsychological disturbances, depression and anxiety. Cluster analysis was used to identify the group with the High level of BDDA (HBDDA).

Results

By multiple logistic analysis, disability, specific behavioural disturbances of the patients as well as caregiver's age, type of relationship and living in the south of Italy were observed to be a major risk factor for HBDDA.

Conclusion

The targeted use of scales specifically assessing BDDA of the caregiver and the identification of particular patient and caregiver characteristics are able to allow a precise and early definition of caregivers at high risk of burden and distress. This might be helpful in planning the correct social/clinical/rehabilitative approach. Copyright Β© 2005 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Cisplatin and gemcitabine with either vi
✍ Sergio Palmeri; Vito Lorusso; Laura Palmeri; Marina Vaglica; Camillo Porta; Rola πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. To date, the standard treatment for patients who have carcinoma of unknown primary site has not been established. ## METHODS. In this randomized Phase II study, 66 previously untreated patients (33 patients per arm) with carcinomas of unknown primary site received cisp

Assessing symptom burden using the M. D.
✍ Janice L. Gabrilove; Edith A. Perez; Dianne K. Tomita; Greg Rossi; Charles S. Cl πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 346 KB

## Abstract ## BACKGROUND. Patients with cancer who are receiving chemotherapy often experience chemotherapy‐induced anemia (CIA), which is associated with symptoms that reduce quality of life. The M. D. Anderson Symptom Inventory (MDASI) is a brief, self‐rating assessment scale that measures the

High dose chlorambucil versus Binet's mo
✍ Branimir Jaksic; Maura Brugiatelli; Ivo Krc; Hajna Losonczi; Jerzy Holowiecki; A πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

vanced and/or progressive disease was defined by high Total Tumor Mass (TTM) score (ΓΊ9), and/or short doubling time (DT) (Γ΅12 months), and/or bone marrow for the International Society for Chemo-Immunotherapy, Vienna failure. The response to therapy was defined by reduction of the initial TTM score.